Drugmakers warily eye the nutraceuticals market

08/30/2011 | PharmExec.com

Unlike the brand-name prescription drug market, the nutraceuticals market is expected to grow over the coming years, and some big drugmakers are tentatively testing the waters while others are steering clear. Drugmakers are nervous about running afoul of FDA regulations, brand-name dilution and low margins, analysts say. But the market may be an excellent opportunity for pharma to refill pipelines. "Given the pipeline gap, pharma can't afford to cede the nutraceuticals market to [consumer goods companies] like Nestlé, a company that is actively climbing over the fence into pharmaceuticals," writes industry expert Ben Comer.

View Full Article in:

PharmExec.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX